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Abstract
Objective:  To  evaluate  alcohol/tobacco  and/or  illicit  drug  misuse  in  Chronic  Diseases  (CDs).
Methods:  A  cross-sectional  study  with  220  CDs  adolescents  and  110  healthy  controls  includ-
ing: demographic/anthropometric  data;  puberty  markers;  modiﬁed  questionnaire  evaluating
sexual function,  alcohol/smoking/illicit  drug  misuse  and  bullying;  and  the  physician-conducted
CRAFFT (car/relax/alone/forget/friends/trouble)  screen  tool  for  substance  abuse/dependence
high risk.
Results:  The  frequencies  of  alcohol/tobacco  and/or  illicit  drug  use  were  similar  in  both  groups
(30% vs.  34%,  p=0.529),  likewise  the  frequencies  of  bullying  (42%  vs.  41%,  p=0.905).  Further
analysis  solely  in  CDs  patients  that  used  alcohol/tobacco/illicit  drug  versus  those  that  did  not
use showed  that  the  median  current  age  [15  (11--18)  vs.  14  (10--18)  years,  p<0.0001]  and
education  years  [9  (5--14)  vs.  8  (3--12)  years,  p<0.0001]  were  signiﬁcant  higher  in  substance
use group.  The  frequencies  of  Tanner  5  (p<0.0001),  menarche  (p<0.0001)  and  spermarche
(p=0.001) were  also  signiﬁcantly  higher  in  patients  with  CDs  that  used  alcohol/tobacco/illicit,
likewise  sexual  activity  (23%  vs.  3%,  p<0.0001).  A  trend  of  a  low  frequency  of  drug  therapy
was observed  in  patients  that  used  substances  (70%  vs.  82%,  p=0.051).  A  positive  correlation
was observed  between  CRAFFT  score  and  current  age  in  CD  patients  (p=0.005,  r=+0.189)  and
controls (p=0.018,  r=+0.226).
Conclusions:  A  later  age  was  evidenced  in  CDs  patients  that  reported  licit/ilicit  drug  misuse.  In
CDs adolescent,  substance  use  was  more  likely  to  have  sexual  intercourse.  Our  study  reinforcesbe  systematically  screened  by  pediatricians  for  drug  related  healththat these  patients  should  
behavioral patterns.
©  2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY  license  (http://creativecommons.org/licenses/by/4.0/).
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Uso  indevido  de  drogas  e  func¸ão  sexual  em  adolescentes  com  doenc¸as crônicas
Resumo
Objetivo:  Avaliar  o  uso  indevido  de  álcool/tabaco  e/ou  de  drogas  ilícitas  em  Doenc¸as  Crônicas
(DCs).
Métodos:  Estudo  transversal  com  220  adolescentes  com  DCs  e  110  controles  saudáveis,
incluindo:  dados  demográﬁcos/antropométricos;  marcadores  de  puberdade;  questionário  modi-
ﬁcado de  avaliac¸ão  da  func¸ão  sexual,  abuso  de  álcool/tabagismo/drogas  ilícitas  e  assédio  moral;
e o  uso  do  instrumento  CRAFFT  (car/relax/alone/forget/friends/trouble)  pelo  medico  para  o
abuso/dependência  de  substâncias  de  alto  risco.
Resultados:  As  frequências  de  uso  de  álcool/tabaco  e/ou  drogas  ilícitas  foram  semelhantes
em ambos  os  grupos  (30%  vs.  34%,  p=0,529),  assim  como  as  frequências  de  assédio  moral  (42%
vs. 41%,  p=0,905).  Uma  análise  mais  aprofundada  apenas  em  pacientes  com  DCs  que  usaram
álcool/tabaco/droga  ilícita  versus  aqueles  que  não  usaram  mostrou  que  a  idade  mediana  atual
[15 (11-18)  vs.  14  (10-18)  anos,  p<0,0001]  e  anos  de  escolaridade  [9  (5-14)  vs.  8  (3-12)  anos,
p<0,0001] foram  signiﬁcativamente  maiores  no  grupo  que  fazia  uso  das  substâncias.  As  fre-
quências de  Tanner  5  (p<0,0001),  menarca  (p<0,0001)  e  espermarca  (p=0,001)  também  foram
signiﬁcativamente  maiores  em  pacientes  com  DCs  que  usaram  álcool/tabaco/drogas  ilícitas,
assim como  a  atividade  sexual  (23%  vs.  3%,  p<0,0001).  A  tendência  de  baixa  frequência  de
terapia com  medicamentos  foi  observada  em  pacientes  que  usaram  substâncias  (70%  vs.  82%,
p=0,051).  Observou-se  uma  correlac¸ão  positiva  entre  o  score  no  CRAFFT  e  idade  atual  em
pacientes  com  DCs  (p=0,005,  r=+0,189)  e  controles  (p=0,018,  r=+0,226).
Conclusões:  A  idade  mais  avanc¸ada  foi  demonstrada  em  pacientes  com  DCs  que  relataram  uso
indevido de  drogas  lícitas/ilícitas.  Em  adolescente  com  DCs,  o  uso  das  substâncias  resultou
em maior  propensão  à  prática  de  relac¸ões  sexuais.  Nosso  estudo  reforc¸a  que  esses  pacientes
devem ser  sistematicamente  avaliados  pelos  pediatras  em  relac¸ão  a  padrões  de  comportamento
de saúde  relacionados  com  drogas.
© 2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este  é  um  artigo
Open Access  sob  a  licença  CC  BY
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dolescence  is  a  developmental  stage  characterized  by  bio-
ogical  and  social  changes.1,2 Risk  patterns  may  begin  in  this
eriod  of  life,  including  substance  misuse  (alcohol,  tobacco
nd  illicit  drugs)1 and  high-risk  sexual  behaviors.3 Harmful
henomena  of  peer  victimization,  such  as  bullying,  is  also  a
elevant  problem  in  healthy  adolescents4 and  in  those  with
hronic  diseases  (CDs).5
Of  note,  the  prevalence  of  chronic  conditions  has
ncreased  in  pediatric  population,6 and  10%  of  adolescents
uffer  from  CDs.7 However,  to  our  knowledge,  misuse  of  sub-
tances  evaluated  by  a  screening  tool,8 as  well  as  assessment
f  bullying  and  sexual  function,  have  not  been  simulta-
eously  studied  in  an  adolescent  CDs  population.
Therefore,  the  objectives  of  the  present  study  were
o  evaluate  alcohol,  tobacco  and/or  illicit  drug  misuse  in
dolescent  CDs  patients  and  healthy  controls.  The  possible
ssociations  between  the  substance  misuse  in  CDs  patients
ccording  to  sexual  function,  bullying,  demographic  data,
uberty  markers,  CDs  groups  and  drug  therapy  use  were  also
ssessed.
ethodrom  February  to  December  2014,  a  cross-sectional  study
as  carried  out  involving  220  consecutive  outpatient  adoles-
ents  (current  age  10--19  years  according  to  World  Health
u
u
m
r (https://creativecommons.org/licenses/by/4.0/deed.pt).
rganization  criteria)  with  pediatric  CDs.  All  of  them  were
ollowed  at  the  Adolescent  Unit  of  our  University  Hospi-
al  and  none  of  them  had  unwillingness  to  participate.  The
ontrol  group  included  110  healthy  adolescents  (rate  2:1),
ithout  CDs,  consecutively  admitted  to  the  outpatient  clinic
nd  referred  from  primary  and  secondary  health  care  ser-
ices  to  the  Adolescent  Unit  of  our  University  Hospital.
his  study  was  approved  by  the  Local  Ethics  Committee  of
ospital.  All  adolescents  and  their  parents  signed  a  con-
ent/assent  term.
This  study  included  a modiﬁed  questionnaire  evaluat-
ng  sexual  function,9 alcohol/tobacco/illicit  drug  use  and
ullying  was  applied.  The  Portuguese  CRAFFT  (mnemonic
cronym  of  car,  relax,  alone,  forget,  friends  and  trouble)
creen  (CRAFFT/CEASER)  version  was  performed  in  both
roups.3,8 Demographic/anthropometric  data  and  puberty
arkers  assessments  were  also  evaluated.
A  pilot  study  was  carried  out  in  30  consecutive  healthy
nd  adolescents  with  CDs,  who  were  tested  and  retested
--2  months.  The  pre-test  evaluated  the  subject  compre-
ension  of  the  questions,  the  consistency  and  coherence  of
he  answers  and  the  time  taken  to  answer  the  questionnaire.
he  modiﬁed  questionnaire  included  14  questions  with  the
ption  of  answer  ‘‘yes/no’’  or  age/number  of  times  about
exual  function,9 bullying  and  alcohol/tobacco/illicit  drugs
9se.  Sexual  function  assessment  included :  age  at  ﬁrst  sex-
al  intercourse,  sexual  intercourse  in  the  last  month,  use  of
ale  contraceptive  (condom)  in  the  ﬁrst  sexual  activity,  cur-
ent  use  of  oral  and  emergency  contraceptive,  knowledge
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of  sexual  activity  by  parents  and  total  number  of  sexual
partners.  Alcohol/tobacco  and  drugs  [illicit  inhalants  drug
(glue  snifﬁng,  aerosol  and  solvents)  and  illicit  drugs  [mari-
juana,  stimulants  (cocaine,  crack  and  speed),  poppers,  LSD,
opiates,  heroin,  crystal  meth  and  ecstasy]  use  were  also
assessed:  age  at  alcohol  initiation,  number  of  days  of  alcohol
use  in  the  last  30  days,  age  at  smoking  initiation,  number  of
days  smoking  cigarettes  in  the  last  30  days,  age  at  illicit  drug
initiation  and  number  of  days  using  illicit  drugs  in  the  last
30  days.  Bullying,  which  is  deﬁned  as  a  recurrent  exposure
to  emotional  and/or  physical  aggression,  was  obtained  by  a
‘‘yes/no’’  answer  to  the  question  (‘‘Have  you  ever  suffered
bullying?’’).  The  questionnaire  was  strictly  conﬁdential  and
was  performed  in  the  absence  of  legal  guardians,  relatives
and  friends.
The  Portuguese  version  of  physician-conducted  CRAFFT
(CRAFFT/CEASER)  screen  was  used  and  consisted  of  9 ques-
tions  developed  to  screen  adolescents  for  high-risk  alcohol
and  drug  misuse.8 This  questionnaire  is  divided  in  two  parts.
Part  A  includes  three  questions  regarding  the  use  of  alcohol,
marijuana/hashish  or  another  substance  in  the  last  twelve
months.  If  the  adolescent  responded  ‘‘no’’  to  all  three  ques-
tions,  only  the  question  related  to  ‘‘car’’  of  the  B--part
should  be  asked.  If  the  adolescent  answered  ‘‘yes’’  to  one  of
the  opening  questions,  all  of  the  questions  of  part  B  should
be  asked.  B-part  contained  six  questions,  which  are  signs
of  problematic  substance  use.  One  point  was  given  to  each
‘‘yes’’  answer  in  the  B-part  of  the  questionnaire.  The  score
ranged  from  0  to  6.  A  total  score  of  ≥2  indicated  high  risk
for  substance  abuse/dependence  and  a  need  for  additional
assessment.3,8
Regarding  socio-demographic  and  anthropometric  data,
current  age,  gender,  years  of  education,  weight  and  height
were  evaluated.  Body  mass  index  (BMI)  was  deﬁned  by  the
formula:  weight  in  kilograms/height  in  square  meters.  The
Brazilian  socio-economic  status  were  classiﬁed  according  to
the  ABEP  (Associac¸a˜o  Brasileira  de  Empresas  de  Pesquisa).10
Secondary  sexual  characteristics  were  classiﬁed  accord-
ing  to  Tanner  pubertal  changes.11 Age  at  ﬁrst  menstruation
(menarche)  and  age  at  ﬁrst  ejaculation  (spermarche)  were
registered  based  on  memory  recollection.
Chronic  diseases,  with  disease  duration  more  than
three  months,  were  classiﬁed  in:  Allergic/Immunologic,
Cardiopulmonary,  Dermatologic,  Endocrinologic,  Gas-
troenterologic,  Hematologic,  Neuropsychiatric,  Renal  and
Rheumatic  conditions.  The  use  of  drug  therapy  was  also
assessed.
The  test--retest  reliability  of  the  modiﬁed  question-
naire  was  veriﬁed  for  CDs  population  and  healthy  controls
using  the  Kappa  index.  Results  were  presented  as  the
mean  ±  standard  deviation  (SD)  or  median  (range)  for  con-
tinuous  and  number  (%)  for  categorical  variables.  Data
were  compared  by  t  or  Mann--Whitney  tests  in  continu-
ous  variables  to  evaluate  differences  between  adolescents
with  CDs  and  controls,  and  between  subgroups.  For  cat-
egorical  variables,  differences  were  assessed  by  Fisher’s
exact  or  Pearson  chi-square  tests.  Spearman  rank  correla-
tion  coefﬁcient  was  used  for  correlations  between  CRAFFT
score  and  age.  The  level  of  signiﬁcance  was  set  at  5%
(p<0.05).
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he  kappa  index  for  test--retest  was  0.850,  demonstrating
xcellent  reliability  for  the  adolescents’  responses.
The  frequencies  of  alcohol,  tobacco  and/or  illicit  drug
se  were  similar  in  both  adolescents  with  CDs  and  healthy
ontrols  (30%  vs.  34%,  p=0.529).  The  frequency  of  alcohol
onsumption  in  the  past  30  days  was  signiﬁcantly  lower
n  adolescents  with  CDs  compared  with  controls  (6%  vs.
7%,  p=0.005).  Illicit  drugs  were  used  by  three  CDs  patients
marijuana,  cocaine  and/or  poppers)  and  three  controls
marijuana)  (p=0.404).  No  difference  was  observed  in  the
requency  of  smoking  (p=0.114).  CRAFFT  score  ≥2  was  simi-
ar  in  both  groups  (4%  vs.  5%,  p=0.575).  The  frequency  of
ullying  was  alike  in  both  groups  (36%  vs.  39%,  p=0.905)
Table  1).  The  median  of  age  onset  smoking  was  14  years
11--15)  in  adolescents  with  CDs  and  was  14  years  (7--15)  in
ealthy  controls.  The  median  of  age  onset  ilicit  drug  use  was
4.5  years  (14--15)  in  adolescents  with  CDs  and  was  14  years
n  healthy  controls.
A  positive  correlation  was  evidenced  between  CRAFFT
core  and  current  age  in  CDs  patients  (p=0.005,  r=+0.189)
nd  healthy  controls  (p=0.018,  r=+0.226),  likewise  between
RAFFT  score  and  education  years  in  CDs  (p=0.015,
=+0.164)  and  controls  (p=0.039,  r=+0.197).  A  positive
orrelation  was  observed  between  CRAFFT  score  and  age
f  alcohol  onset  in  CDs  patients  (p=0.021,  r=+0.286)
Table  1).
The  median  current  age  was  similar  between  adolescent
ith  CDs  and  healthy  controls  [14  (10--18)  vs.  14  (10--18)
ears,  p=0.778],  likewise  the  frequency  of  female  gender
65%  vs.  67%,  p=0.742),  years  of  education  [9  (3--14)  vs.  8
4--12)  years,  p=0.857],  Brazilian  socio-economic  classes  B
r  C  (95%  vs.  94%,  p=0.365)  and  between  Tanner  3,  4  and
 (p=0.582).  The  median  menarche  age  was  signiﬁcantly
igher  in  the  former  group  [12  (8--16)  vs.  11  (9--15)  years,
=0.009].  No  difference  was  evidenced  in  the  age  at  sper-
arche  in  both  groups  (p=0.642)  (Table  2).
Further  analysis  solely  of  patients  with  CDs  regarding
lcohol/tobacco/illicit  drug  misuse  showed  that  the  median
urrent  age  [15  (11--18)  vs.  14  (10--18)  years,  p<0.0001]  and
ducation  years  [9  (5--14)  vs.  8  (3--12)  years,  p<0.0001]  were
igniﬁcant  higher  in  those  that  used  the  aforementioned  sub-
tances.  The  frequencies  of  Tanner  5  (p<0.0001),  menarche
p<0.0001)  and  spermarche  (p=0.001)  were  also  signiﬁcantly
igher  in  the  former  group,  likewise  sexual  activity  (23%  vs.
%,  p<0.0001)  (Table  3).
Of  our  9  patients  with  CDs  with  CRAFFT  score  ≥2,
heumatic  diseases  were  found  in  8  (juvenile  idiopathic
rthritis  in  three  patients,  juvenile  dermatomyositis  in
ne,  childhood-onset  systemic  lupus  erythematosus  in  one,
jögren  syndrome  in  one,  Takayasu  arteritis  in  one  and
enoch--Schönlein  purpura  in  one)  and  Allergic  disease  in
ne  patient  (asthma).
The  frequencies  of  chronic  conditions  in  patients  that
sed  alcohol/tobacco/illicit  drug  versus  those  that  did  not
se  were  similar  (p>0.05).  A  trend  of  a  low  frequency  of
rug  therapy  was  evidenced  in  patients  that  used  substances
ompared  to  those  that  did  not  used  (70%  vs.  82%,  p=0.051)
Table  4).
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Table  1  Alcohol,  smoking  and  illicit  drug  use,  and  bullying  in  adolescents  with  chronic  diseases  and  healthy  controls.
Variables  Chronic  diseases  (n=220)  Healthy  controls  (n=110)  p-value
Alcohol,  smoking  and/or  illicit  drug  use  66  (30)  37  (34)  0.529
Alcohol use  66  (30)  37  (34)  0.529
Age at  onset  alcohol,  yrs  14  (6--17)  14  (7--18)  0.935
Drinking alcohol  in  past  30  days  4/66  (6)  10/37  (27)  0.005
Smoking use  5  (2)  7  (6)  0.114
Illicit drug  use  3  (1)  3  (3)  0.404
CRAFFT score  in  the  last  12  months  (0--6)  0  (0--5)  0  (0--5)  0.712
CRAFFT score  ≥2  9  (4)  6  (5)  0.575
CRAFFT item
Car  41  (19) 17  (15) 0.474
Relax 6/36  (17) 5/27  (19) 1.000
Alone 1/36  (3)  2/27  (7)  0.572
Forget 1/36  (3)  4/27  (15)  0.155
Familiy/friends  8/36  (22)  7/27  (26)  0.733
Trouble 6/36  (17)  0/27  (0)  0.033
Bullying 80  (36)  43  (39)  0.905
Sexual function
Sexual  activity 20  (9) 16/109  (15) 0.126
First sexual  activity  age,  yrs 15  (8--16) 14  (10--17) 0.859
Sexual intercourse  in  last  month 3/20  (15) 6/16  (38) 0.146
Condom at  the  ﬁrst  sexual  activity  19/20  (95)  13/16  (81)  0.303
N Oral  contraception  use  in  females  2/13  (15)  3/13  (23)  1.000
Emergency contraceptive  usea 1/13  (8)  6/13  (46)  0.073
Knowledge of  sexual  activity  by  parents  9/20  (45)  11/16  (69)  0.154
Total number  of  sexual  partner,  number  1  (1--16)  1  (1--5)  0.586
The results are presented in n (%) and median (range), CRAFFT (car, relax, alone, forget, friends, trouble) screening test; BMI, body mass
index.
a One healthy control used oral contraception before sexual activity.
Table  2  Demographic  data  and  puberty  markers  in  adolescents  with  chronic  diseases  and  healthy  controls.
Variables  Chronic  diseases  (n=220)  Healthy  controls  (n=110)  p-value
Demographic  data
Current  age,  yrs  14  (10--18)  14  (10--18)  0.778
Female gender  144  (65)  74  (67)  0.742
BMI, kg/m2 21  (12--39)  21  (13--29)  0.091
Social economic  class  B  and  C  211  (95)  103  (94)  0.365
Education, yrs  9  (3--14)  8  (4--12)  0.857
Puberty markers
Tanner  3  53  (24)  23  (21)  --
Tanner 4  52  (24)  29  (26)  --
Tanner 5  77  (35)  46  (42)  0.582
Menarche 113/144  (78)  65/74  (88)  0.091
Menarche age,  yrs  12  (8--16)  11  (9--15)  0.009
Spermarche 38/76  (50)  23/36  (64)  0.168
Spermarche age,  yrs  12  (10--15)  13  (8--14)  0.642
mass
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iscussion
ur  study  evaluated  simultaneously  adolescent’s  health
roblems  in  CDs  patients  and  healthy  controls.  In  adoles-
ents  with  CDs,  substance  use  was  observed  in  later  age  and
as  more  likely  to  sexual  intercourse  compared  to  those  that
id  not  use  licit/illicit  drug.
t
s
v
a index.
The  advantage  of  this  study  was  the  assessment  of
hysician-conducted  CRAFFT  (CEASER)  screening  tool  for
ubstance  misuse  in  adolescents.3,8 The  use  of  the  ques-
ionnaire  with  excellent  test--retest  reliability  regarding
exual  function,  bullying  and  substances  use  was  also  rele-
ant.  Additionally,  a  healthy  control  group  with  comparable
ge,  gender,  education  and  socio-economic  class  was  also
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Table  3  Demographic  data,  puberty  markers  and  bullying  in  adolescents  with  chronic  diseases  according  to  alcohol,  smoking
and illicit  drug  use.
Variables  Use  alcohol,
smoking  and/or
illicit  drug  (n=66)
Non  use  alcohol,
smoking  and/or
illicit  drug  (n=154)
p-value
Demographic  data
Current  age,  yrs  15  (11--18)  14  (10--18)  <0.0001
Female gender  43  (65)  101  (66)  0.951
BMI, kg/m2 21  (17--38)  21  (12--39)  0.275
Social economic  class  B  and  C  62  (94)  149  (97)  0.457
Education, yrs 9  (5--14)  8  (3--12)  <0.0001
Puberty markers
Tanner  3 13  (20) 40  (26) --
Tanner 4  15  (23)  37  (24)  --
Tanner 5  36  (55)  41  (27)  <0.0001
Menarche 42/43  (98)  71/101  (70)  <0.0001
Menarche age,  yrs  12  (9--16)  12  (8--15)  0.348
Spermarche 18/23  (78)  20/53  (38)  0.001
Spermarche age,  yrs  12  (10--14)  12.50  (10--15)  0.668
Sexual function
Sexual  activity 15  (23) 5  (3) <0.0001
First sexual  activity  age,  yrs 14.50  (8--16) 15  (14--15) 0.702
Sexual intercourse  in  last  month  3/15  (20)  0/5  (0)  0.539
Condom at  the  ﬁrst  sexual  activity  14/15  (93)  5/5  (100)  1.000
N Oral  contraception  use  in  females  2/11  (18)  0/2(0)  1.000
Emergency contraceptive  use  1/11  (9)  0/2  (0)  1.000
Knowledge of  sexual  activity  by  parents  6/15  (40)  3/5  (60)  0.617
Total number  of  sexual  partner,  number  1  (1--6)  1  (1--16)  1.000
Bullying 24  (36)  55  (36)  0.685
The results are presented in n (%) and median (range); CRAFFT (car, relax, alone, forget, friends, trouble) screening test; BMI, body mass
index.
Table  4  Adolescent  chronic  diseases  and  drug  therapy  according  to  alcohol,  smoking  and  illicit  drug  use  the  results  are  presented
in n  (%).
Variables  Use  alcohol,
smoking  and/or
illicit  drug  (n=66)
Non  use  alcohol,
smoking  and/or
illicit  drug  (n=154)
p-value
Adolescent  chronic  diseases
Immunologic  3  (5)  2  (1)  0.160
Dermatologic  3  (5)  3  (2)  0.367
Endocrinologic  12  (18)  33  (21)  0.715
Gastroenterologic  2  (3)  11  (7)  0.352
Neuropsychiatric  7  (11)  20  (13)  0.822
Allergic/cardiopulmonary  9  (14)  23  (15)  1.000
Renal 5  (8)  5  (3)  0.170
Rheumatic 46  (70)  112  (73)  0.743
Hematologic  0  (0)  1  (1)  1.000
a
a
a
aDrug therapy  for  chronic  diseases  46  (70)  
observed  in  our  study,  since  these  data  were  previously
related  with  bullying  and  substance  misuse.1,3,12,13
Alcohol  intake  was  reported  by  approximately  one  third
of  our  CDs  patients,  even  though  a  low  intake  frequency
in  the  last  month.  The  prevalence  of  alcohol  use  in  ado-
lescents  varies  from  7.8%  to  78.9%12,14,15 around  the  world
and  from  26%  to  71%  in  Brazil.16--21 There  are  studies  in
ﬁ
a
B126  (82)  0.051
dolescents  with  speciﬁc  CDs,  generally  with  small  samples
nd  variable  frequencies  of  alcohol  use  (4.8%--70%),  such
s  juvenile  idiopathic  arthritis,22 obesity  and  overweight,23
sthma,24 cystic  ﬁbrosis  and  sickle  cell  disease.25 This
nding  in  our  CDs  patients  may  be  related  to  the  avail-
bility  of  alcohol  at  parties,  pubs,  stores  and  homes  in
razil.16
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Importantly  in  the  evaluation  of  only  adolescents  with
Ds,  we  observed  that  use  of  alcohol,  tobacco  and  illicit
rugs  occurred  in  CDs  patients  that  presented  higher  age,
igher  education  background  and  post  pubertal  markers.
he  avoidance  of  substance  use  in  early  adolescence  may  be
elated  to  overprotection  of  parents  and  primary  caregivers.
n  contrast,  a  more  liberal  parental  attitude  may  contribute
o  an  increase  in  substance  misuse  later  on  in  life.  Moreover,
evere  CDs  that  required  higher  frequencies  of  medication
ay  have  contributed  to  the  low  use  of  illicit  and  licit  drugs.
The  adolescents  may  develop  a  drinking  pattern  that
s  socially  acceptable  and  a  small  group  of  CDs  patients’
isused  alcohol  more  frequently.  We  applied  a  screening
rocedure  for  substance  misuse  and  4%  of  our  CDs  patients
ad  a  higher  risk  for  substance  abuse/dependence.  A  posi-
ive  correlation  was  also  evidenced  between  CRAFFT  score
nd  current  age,  indicating  a  higher  risk  for  harmful  sub-
tance  misuse  in  older  CDs  adolescents.
Smoking  was  reported  only  by  2%  of  our  CDs  patients.  This
spect  has  also  been  observed  in  adolescents  of  our  conti-
ental  country  due  to  ban  on  smoking  advertising,26 use  of
arnings  on  cigarettes  packages27 and  prohibition  in  public
laces.28 The  use  of  any  illicit  drug  (marijuana,  solvents,
ocaine  or  crack)  was  reported  in  2.8%  of  adolescents  in  a
razilian  survey,21 and  this  result  was  higher  than  in  our  CDs
atients.
Interestingly,  CDs  substance  users  engaged  more  in  sexual
ctivity,  and  may  present  a  higher  risk  for  sexually  transmit-
ed  diseases,  unwanted  pregnancy  and  low  contraceptive
se.29,30 This  ﬁnding  may  also  be  related  to  the  fact  that  the
atients  were  older  and  probably  had  higher  sexual  maturity.
owever,  this  study  did  not  evaluate  if  drinking  inﬂuenced
igh-risk  sexual  behavior  in  CDs  patients.
In  addition,  bullying  was  frequently  reported  in  CDs
nd  seems  not  to  be  linked  to  substance  use.  Ado-
escents  with  CDs  may  suffer  from  this  victimization,4,5
ay  induce  anxiety-depressive  disorder  and  interfere  with
roper  adherence  to  medication  use.  A  prospective  study
valuating  prevalence  and  intensity  of  bullying  in  a  large
ample  of  CDs  patients  will  be  required.
The  main  limitation  of  the  present  study  was  the  use  of
 convenience  sample  for  CDs  patients  in  a  tertiary  Univer-
ity  Hospital,  predominantly  of  rheumatic,  endocrinologic,
llergic  and  cardiopulmonary  diseases.  A  small  sample  may
lso  have  reduced  our  power  to  detect  differences  between
he  two  groups  and  the  cross  sectional  design  nature  of  our
tudy  did  not  allow  the  evaluation  of  temporality  between
xposure  and  outcome.  We  did  not  evaluate  disease  activity
riteria  for  all  CDs,  and  indeed  this  ﬁnding  may  modify  the
ehavior.  Moreover,  the  healthy  controls  and  CDs  patients
ere  referred  to  the  adolescent  clinic  of  our  University  Hos-
ital  to  guidance  about  sexual  function  and  birth  control,
motional  problems  and  drugs  issues.
A  need  for  additional  assessment  and  therapeutic  inter-
ention  with  a  multidisciplinary  and  multiprofessional  team
s  required  for  CDs  adolescents  and  families  at  risk  for
ubstance  misuse.  Conﬁdential  discussion  of  illicit  and
icit  drugs  and  other  potentially  risky  behaviors  should  be
ncluded  in  the  routine  care  of  clinics  that  followed-up  CDs
atients.
In  conclusion,  a  later  age  was  evidenced  in  CDs  patients
hat  reported  licit/ilicit  drug  use.  CDs  substance  users  were
1Araújo  P  et  al.
ore  likely  to  have  sexual  intercourse.  Our  study  reinforces
hat  these  patients  should  be  systematically  screened  by
ediatricians  for  sexual,  alcohol  and  drug  related  health
ehavioral  patterns.
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